Latest Crucell Stories
NEW BRUNSWICK, N.J., Oct.
NEW BRUNSWICK, N.J., Sept.
LEIDEN, The Netherlands and SEATTLE, May 3, 2011 /PRNewswire/ -- ProFibrix B.V., a leader in the development of innovative products that help stop bleeding (hemostasis) after surgery, today announced the successful closing of a series B follow-on financing.
LELYSTAD, The Netherlands, March 10, 2011 /PRNewswire/ -- Pepscan Therapeutics, the Dutch biotechnology firm focusing on protein mimicry technology, today announces that it has signed a Research and License Agreement with Crucell Holland B.V.
NEW BRUNSWICK, N.J., and LEIDEN, Netherlands, March 8, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) and Crucell N.V.
- The act of sweetening by admixture of some saccharine substance.